Transl Neurodegener

Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer's disease.

Gómez de San José N, Halbgebauer S, Steinacker P, ..., Parnetti L, Otto M

Transl Neurodegener 13 (1) 57 [2024-11-29; online 2024-11-29]

Novel data-driven subtypes and stages of brain atrophy in the ALS-FTD spectrum.

Shen T, Vogel JW, Duda J, ..., Irwin DJ, McMillan CT

Transl Neurodegener 12 (1) 57 [2023-12-07; online 2023-12-07]

Combined metabolic activators improve cognitive functions in Alzheimer's disease patients: a randomised, double-blinded, placebo-controlled phase-II trial.

Yulug B, Altay O, Li X, ..., Uhlén M, Mardinoglu A

Transl Neurodegener 12 (1) 4 [2023-01-26; online 2023-01-26]

Adil Mardinoglu DDLS Fellow Muhammad Arif Saeed Shoaie SciLifeLab Fellow

Altered levels of CSF proteins in patients with FTD, presymptomatic mutation carriers and non-carriers.

Remnestål J, Öijerstedt L, Ullgren A, ..., Graff C, Nilsson P

Transl Neurodegener 9 (1) 27 [2020-06-23; online 2020-06-23]